In addition, we explored the relationships between disease stage, cognition, regional tau deposition and regional centile scores in amyloid-β-PET-positive individuals with Alzheimer’s disease dementia (n = 39) and mild cognitive impairment (n = 71) from the Alzheimer’s Disease Neuroimaging Initiative-3 (ADNI-3). This evidence concerns the gene MAPT and dementia.